Clarifying the role played by systemic AP regulators in AMD requires careful consideration of their effect at the RPE/Bruch’s membrane/choroid interface and their potential interactions with the risk and protective forms of FH/FHL-1 and/or FHR-1 and FHR-3. The gene discussed is FHL1; the disease is age-related macular degeneration.